{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-078354","form_type":"8-K","ticker":"MIST","cik":"0001408443","company_name":"Milestone Pharmaceuticals Inc.","filed_at":"2022-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.645128+00:00","generated_at":"2026-06-24T18:16:55.870673+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Milestone Pharmaceuticals shareholders elect directors, approve auditor and equity plan amendment at 2022 meeting","bullets":["All six director nominees elected: Joseph Oliveto, Lisa M. Giles, Richard Pasternak, Debra K. Liebert, Michael Tomsicek, Robert J. Wills. Votes for each ranged 19,105,725 – 19,110,012.","PricewaterhouseCoopers LLP appointed as auditor for 2023 with 24,809,612 votes for, 0 against, 217,072 withheld.","Amendment to 2019 Equity Incentive Plan approved; increase of 1,000,000 shares authorized. 15,462,071 for, 3,652,167 against, 5,912,446 broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-078354","json":"https://secwatch.observer/filing/0001104659-22-078354.json","markdown":"https://secwatch.observer/filing/0001104659-22-078354.md","text":"https://secwatch.observer/filing/0001104659-22-078354.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1408443/000110465922078354/0001104659-22-078354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1408443/000110465922078354/tm2220674d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T18:16:55.870673+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}